Evotec SE EVO
NASDAQ EVO
$1.60 -0.04 (-2.44%)
At close: Oct 2, 2026 · 4:00 PM EDT

Evotec SE (EVO) Income from Non-Controlling Interests (2009 - 2019)

Updated

Evotec SE (EVO) reported Income from Non-Controlling Interests of -$945,219 for the year ended Dec 31, 2019.

Analysis

Evotec SE (EVO) Income from Non-Controlling Interests (2009 - 2019) Analysis & Trends

  • The figure for the year ended Dec 31, 2019 ranks as the highest annual Income from Non-Controlling Interests since the year ended Dec 31, 2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Iqvia Holdings 42.51 Bn 34.35 Bn 1.44 Bn 2.00 Mn
2 Medpace Holdings 16.73 Bn 14.79 Bn 201.64 Mn -
3 Charles River Laboratories International 13.84 Bn 13.08 Bn 363.37 Mn 722,000.00
4 Icon 12.41 Bn 9.52 Bn 479.29 Mn -
5 Fortrea Holdings 1.90 Bn 1.28 Bn 139.20 Mn -
6 Ginkgo Bioworks Holdings 786.20 Mn 24.11 Mn 18.44 Mn -
7 Evotec SE 568.89 Mn -1.00 Bn - -
8 Champions Oncology 68.76 Mn 44.41 Mn 7.70 Mn -
9 MindWalk Holdings 62.59 Mn 26.81 Mn 1.61 Mn -
10 Natural Alternatives International 8.92 Mn -19.16 Mn 1.73 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 -677,415.26
Sep 30, 2010 -550,082.14
Jun 30, 2010 200,149.49
Mar 31, 2010 51,234.26
Mar 31, 2009 -18,678.36
API Access

Evotec SE Income from Non-Controlling Interests API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=EVO&period=max&api_key=YOUR_API_KEY